Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide
Background: Although the outcome of allogeneic hematopoietic stem cell transplantation (allo-HSCT) has dramatically improved in the past decade, it is still compromised by transplant-related mortality (TRM), mainly caused by Graft-vs. -Host Disease (GvHD).Methods: We conducted a prospective observat...
Váldodahkkit: | , , , , , , , , , , , , , , , |
---|---|
Materiálatiipa: | Artihkal |
Giella: | English |
Almmustuhtton: |
Frontiers Media S.A.
2019-10-01
|
Ráidu: | Frontiers in Immunology |
Fáttát: | |
Liŋkkat: | https://www.frontiersin.org/article/10.3389/fimmu.2019.02319/full |